<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04457115</url>
  </required_header>
  <id_info>
    <org_study_id>ELETTRA</org_study_id>
    <secondary_id>2613</secondary_id>
    <nct_id>NCT04457115</nct_id>
  </id_info>
  <brief_title>Erector Spinae Plane Block Versus Thoracic Paravertebral Block for Pain Control in Modified Radical Mastectomy</brief_title>
  <official_title>Comparison of Efficacy of Ultrasound-guided Erector Spinae Plane Block Versus Thoracic Paravertebral Block for Intra and Postoperative Pain Control in Modified Radical Mastectomy: a Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AUSL Romagna Rimini</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AUSL Romagna Rimini</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the effectiveness of the Erector spinae plane (ESP) block
      versus thoracic paravertebral (TPV) block in the post-operative pain control after radical
      mastectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary outcome of our study is to compare the effectiveness of two regional anesthesia
      techniques, ESP block and TPV block, in the post-operative pain-control after radical
      mastectomy.

      We will also evaluate both intra and post-operative opioid consumption, the incidence of
      PONV, the length of hospital stay, patient satisfaction with the anesthesiology technique and
      the incidence of chronic pain 6 months after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 27, 2020</start_date>
  <completion_date type="Anticipated">April 27, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 27, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative pain assessment</measure>
    <time_frame>36 hours</time_frame>
    <description>post-operative pain assessment using Numeric rating scale (from 0,no pain, to 10 ,worst pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>3 days</time_frame>
    <description>The number of days of hospitalization after surgery will be assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the incidence and severity of persistent pain 6 months after surgery</measure>
    <time_frame>six months</time_frame>
    <description>Evaluate the incidence and severity of persistent pain 6 months after surgery using Numeric rating scale (from 0, no pain, to 10, worst pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid use</measure>
    <time_frame>36 hours</time_frame>
    <description>Intra and post-operative opioid use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of PONV</measure>
    <time_frame>36 hours</time_frame>
    <description>Incidence of post operative nausea and vomiting (PONV) in the first 36 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of patient satisfaction with the anesthesiological technique</measure>
    <time_frame>36 hours</time_frame>
    <description>Patients is requested to fill out a pre-printed sheet on their judgment of the anesthesiological procedure, in which they can express a value from 0 to 5, where 0 indicates &quot;entirely dissatisfied&quot; and 5 indi- cates &quot;very satisfied&quot;</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Breast Surgery</condition>
  <condition>Thoracic Paravertebral Block</condition>
  <condition>Post-operative Pain Control</condition>
  <condition>Erector Spinae Plane Block</condition>
  <condition>Opioid Use</condition>
  <arm_group>
    <arm_group_label>TPV Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Thoracic paravertebral block performed at thoracic level T2-T3 and T4-T5 with administration of Ropivacaine 0.7% 8 ml for each level.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ESP Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Erector spinae plane block performed at thoracic level T2 and T5 with administration of Ropivacaine 0.5% 12 ml for each level.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thoracic paravertebral block</intervention_name>
    <description>Thoracic paravertebral block performed at T2-T3 and T4-T5 levels with administration of Ropivacaine 0.7% 8 ml for each level</description>
    <arm_group_label>TPV Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Erector spinae plane Block</intervention_name>
    <description>Erector spinae plane block performed at T2 and T5 levels with administration of Ropivacaine 0.5% 12 ml for each level</description>
    <arm_group_label>ESP Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged between 18 and 85

          -  American Society of Anesthesiologists classification I - III

          -  Signature of consent to participate in the study

        Exclusion Criteria:

          -  Coagulopathies and / or use of antiplatelet / anticoagulant drugs

          -  Infections and/or lesions at the puncture site,

          -  BMI â‰¥40

          -  allergies and / or contraindications to the administration of the drugs used in the
             study,

          -  use of chronic opioid therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Domenico P Santonastaso, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AUSL Romagna, M. Bufalini Hospital, Cesena</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Domenico P Santonastaso, MD</last_name>
    <phone>+39 3492585491</phone>
    <email>domenicopietro.santonastaso@auslromagna.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Domenico Pietro Santonastaso</name>
      <address>
        <city>Cesena</city>
        <state>Emilia Roamgna</state>
        <zip>47521</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domenico P Satonastaso</last_name>
      <phone>+39 3492585491</phone>
      <email>domenicopietro.santonastaso@auslromagna.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 22, 2020</study_first_submitted>
  <study_first_submitted_qc>June 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2020</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>breast surgery</keyword>
  <keyword>Thoracic paravertebral block</keyword>
  <keyword>Erector spinae plane block</keyword>
  <keyword>Mastectomy</keyword>
  <keyword>post-operative pain control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

